Sildenafil Citrate Tablet, Film Coated
Product Images NDC 71335-1437

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71335-1437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

A line graph showing the mean change from baseline in sitting systolic blood pressure over time in hours after dosing, comparing Sildenafil 100 mg with placebo in healthy volunteers. The Y-axis measures systolic blood pressure in mmHg, and the X-axis represents time post dose from pre-dose up to 24 hours.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph depicting mean standing systolic blood pressure change from baseline over time in hours postdose. Two groups are shown: one treated with Doxazosin plus placebo, and another with Doxazosin plus Sildenafil 50 mg. The y-axis represents the change in blood pressure (mmHg), and the x-axis shows time postdose from 0 to 8 hours.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

Line graph depicting mean standing systolic blood pressure change from baseline over 8 hours after dosing. Two groups are compared: one receiving Doxazosin with Sildenafil 100 mg, and the other Doxazosin with Placebo. The y-axis shows blood pressure changes in mmHg, and the x-axis shows time after dosing in hours.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line graph titled "Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers" showing the plasma concentration (ng/ml) of sildenafil over time (hours) after dosing with a commercial tablet. The graph illustrates a rapid increase in plasma levels, peaking around 1 hour post-dose, followed by a gradual decline over 24 hours.*

FDA Label Image

Label Image (Lbl713351437)

Label for Sildenafil Citrate 100 mg tablet, film coated, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the product is comparable to Viagra 100 mg tablet (Ajanta Pharma USA Inc.). It includes storage instructions at 20°-25°C (68°-77°F), a warning to keep drugs out of children's reach, lot number 1523487, and NDC 71335-1437-1. Barcode present on the label.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

A bar graph illustrating the percentage of patients reporting improved erections after treatment with placebo and various doses of Sildenafil Tablets (25 mg, 50 mg, and 100 mg). The graph shows increasing improvement percentages corresponding to higher doses of Sildenafil, with placebo having the lowest.*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure diagram of sildenafil citrate, the active ingredient in the product Sildenafil Citrate 100 mg film-coated tablets by Bryant Ranch Prepack.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph comparing the change in BPI (mmHG) over time in hours postdose between two treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The graph shows BPI change on the y-axis and time postdose on the x-axis, with two lines representing the two treatment groups.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart showing the percentage of patients at endpoint across different baseline scores ranging from 0 to 5. Multiple bars of varying heights represent distinct categories or groups at each baseline score, with a legend to the right indicating the groups with color coding.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar chart displaying the percentage of patients at endpoint categorized by baseline score. The vertical axis shows the percentage of patients, and the horizontal axis shows the baseline score ranging from 0 to 5. Multiple bars for each baseline score suggest comparisons among different groups or treatments.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.